UBC Day - From Lab to Market: Tours and Venture Connections
UBC Day, in partnership with the Life Sciences BC Invest in BC Conference.
On a local and global level, we are seeing the outcomes of UBC research generate positive social, health, environmental and economic benefits. From lab to market, UBC is a leader in translating cutting edge research to real-world impact in the life sciences. We are thrilled to have you join us for this inaugural UBC Day, in partnership with the Life Sciences BC Invest in BC Conference.
UBC Day is a collaboration among Innovation UBC, School of Biomedical Engineering (SBME), the Faculty of Medicine, Canada’s Immuno-Engineering and Biomanufacturing Hub (CIEBH) and the Faculty of Pharmaceutical Sciences.
Agenda for UBC Day: Thursday Oct 30, 2025
7:30 AM - 10:30 AM - UBC Innovation & Industry Breakfast hosted by UBC's School of Biomedical Engineering (separate registration)
11:00 AM - 2:00 PM - From Lab to Market: Tours and Venture Connections hosted by Innovation UBC
Details on From Lab to Market: Tours and Venture Connections
Attendees will be able to join tours in small groups, with short presentations from distinguished researchers about innovations they are working on in their labs. Following the tours, guests are invited back to the Graham Lee Innovation Centre in the lower level of the Alumni Centre for a light lunch and to meet some of our up and coming Life Sciences ventures.
Confirmed Tours*:
Djavad Mowafaghian Centre for Brain Health: PROGENITER with Dr. Sriram Subramaniam
Pharmaceutical Sciences Building with Dr. Colin Ross (Genome Editing), Dr. Joel A. Finbloom (antibiotic resistant bacterial infections), Dr. Shyh-Dar Li (needle-free drug delivery) and Dr. Miffy Hok Yan Cheng (Next Gen nanomedicines)
*Tours will run about 20 minutes each and will include up to 15 people per group, rotating through each lab.
Please meet us in the entrance of the Gordon B. Shrum building (6088 University Boulevard).We will depart promptly at 11:00 am.
UBC’s Faculty of Pharmaceutical Sciences conducts innovative and ground-breaking research that spans the complete therapeutic journey of medicines: from drug development to population-wide epidemiological studies of drug effectiveness, drug safety, and pharmacy practice. Our Innovation Day tours will highlight recent advances in the development of precision medicines: developing the next generation of nanomedicines (Miffy Cheng), treating neurodegenerative and other genetic diseases with genome editing (Colin Ross), developing needle-free drug delivery systems (Shyh-dar Li), and designing smart nanomaterials to treat antibiotic-resistant bacterial infections (Joel Finbloom).
Who should attend
This invite-only event is designed for industry leaders, investors, and innovation partners seeking high-impact collaboration opportunities across UBC’s life sciences community.
Your registration will be reviewed by our team. If approved, you will receive a confirmation email confirming your participation.
About Innovation UBC
Innovation UBC works with UBC’s researchers to support and accelerate the translation of their research into real world impacts. Through research partnerships, technology transfer, and venture building services, UBC researchers have access to a robust ecosystem of services and support to strengthen their translation opportunities. Our successful history of translation and commercialization has led to the creation of 275 spin-off companies, establishing over 500 active licensing agreements, and enabling thousands of research partnerships each year with industry, government, and non-profit organizations. We support $190M+ annually in sponsored research activities (which is more than 80% of provincial sponsored research funding). UBC licensed technologies have attracted over $8.4 billion in investment capital and generated over $13 billion in revenues. 91% of UBC spin-off companies remain in Canada, 88% in BC.
Our mission is to help create impact from UBC’s breakthrough research to generate social, health, environmental and economic benefits.